Current Pharmaceutical Trends in Neuroimmunology - Part I: Disorders Affecting the CNS

Curr Pharm Des. 2022;28(6):427. doi: 10.2174/138161282806220218141218.NO ABSTRACTPMID:35379121 | DOI:10.2174/138161282806220218141218

Source: Current Pharmaceutical Design - April 5, 2022 Category: Drugs & Pharmacology Authors: Paulus S Rommer Uwe K Zettl Source Type: research